Table 2.
Average skin quality scores for the per protocol population as assessed by the skin quality VAS questionnaire
|
VWC Mean ± SD (n) |
Placebo Mean ± SD (n) |
Baseline between‐Group P‐value a |
|
|---|---|---|---|
| Overall Score | |||
| Baseline | 0.59 ± 1.97 (17) | 2.63 ± 11.47 (19) | 0.538 (r) |
| Week 6 | 46.41 ± 29.40 (17) | 38.42 ± 30.63 (19) | |
| Week 12 | 54.94 ± 31.82 (17) | 52.42 ± 34.28 (19) | |
| Elasticity Score | |||
| Baseline | 0.41 ± 1.28 (17) | 2.63 ± 11.47 (19) | 0.538 (r) |
| Week 6 | 38.71 ± 30.76 (17) | 31.26 ± 28.22 (19) | |
| Week 12 | 50.35 ± 30.38 (17) | 43.26 ± 37.10 (19) | |
| Hydration Score | |||
| Baseline | 0.47 ± 1.50 (17) | 2.63 ± 11.47 (19) | 0.538 (r) |
| Week 6 | 41.35 ± 30.12 (17) | 37.32 ± 31.31 (19) | |
| Week 12 | 50.24 ± 30.65 (17) | 46.37 ± 34.75 (19) | |
| Radiance Score | |||
| Baseline | 0.41 ± 1.28 (17) | 1.32 ± 5.74 (19) | 0.538 (r) |
| Week 6 | 42.06 ± 30.15 (17) | 35.47 ± 31.31 (19) | |
| Week 12 | 49.35 ± 29.43 (17) | 41.47 ± 31.19 (19) | |
| Firmness Score | |||
| Baseline | 0.47 ± 1.50 (17) | 1.32 ± 5.74 (19) | 0.538 (r) |
| Week 6 | 41.76 ± 31.91 (17) | 31.58 ± 32.65 (19) | |
| Week 12 | 48.18 ± 31.01 (17) | 39.37 ± 32.87 (19) | |
| Wrinkle Score | |||
| Baseline | 0.53 ± 1.74 (17) | 2.63 ± 11.47 (19) | 0.538 (r) |
| Week 6 | 39.24 ± 26.04 (17) | 28.21 ± 27.46 (19) | |
| Week 12 | 46.41 ± 32.27 (17) | 42.53 ± 36.57 (19) | |
Probability values P ≤ .05 are statistically significant
Abbreviations: n, number; SD, standard deviation.
a
For Baseline (Day 0), between group p‐value generated by ANOVA with Group as a fixed effect (r) indicates values were ranked prior to generating ANOVA or ANCOVA